Skip to Content
MilliporeSigma

Y0000767

Resorcinol

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

1,3-Benzenediol

Slide 1 of 1
Sign In to View Organizational & Contract Pricing

Select a Size

30 MG

$131.20

$131.20

List Price$164.00Save 20%
Check Cart for Availability
Request a Bulk Order

About This Item

Linear Formula:
C6H4-1,3-(OH)2
CAS Number:
108-46-3
Molecular Weight:
110.11
Beilstein/REAXYS Number:
906905
MDL number:
MFCD00002269
UNSPSC Code:
41116107
PubChem Substance ID:
329831139
NACRES:
NA.24

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

pharmaceutical primary standard

vapor density

3.8 (vs air)

vapor pressure

1 mmHg ( 21.1 °C)

API family

resorcinol

autoignition temp.

1126 °F

manufacturer/tradename

EDQM

bp

178 °C/16 mmHg (lit.)

mp

109-112 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

Oc1cccc(O)c1

InChI

1S/C6H6O2/c7-5-2-1-3-6(8)4-5/h1-4,7-8H

InChI key

GHMLBKRAJCXXBS-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
PHR1201161011.07590
Resorcinol European Pharmacopoeia (EP) Reference Standard

Y0000767

Resorcinol

Resorcinol Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1201

Resorcinol

Resorcinol meets analytical specification of Ph. Eur., BP, 98.5-100.5% (calc. to the dried substance)

Sigma-Aldrich

16101

Resorcinol

Resorcinol extra pure

SAFC

1.07590

Resorcinol

grade

pharmaceutical primary standard

grade

certified reference material, pharmaceutical secondary standard

grade

-

grade

-

manufacturer/tradename

EDQM

manufacturer/tradename

-

manufacturer/tradename

-

manufacturer/tradename

-

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

application(s)

pharma/biopharma processes

format

neat

format

neat

format

-

format

-

vapor density

3.8 (vs air)

vapor density

3.8 (vs air)

vapor density

3.8 (vs air)

vapor density

-

vapor pressure

1 mmHg ( 21.1 °C)

vapor pressure

1 mmHg ( 21.1 °C)

vapor pressure

1 mmHg ( 21.1 °C)

vapor pressure

0.1 hPa ( 20 °C)

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Resorcinol EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

Product No.
Description
Pricing

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 3 - Eye Dam. 1 - Skin Irrit. 2 - Skin Sens. 1B - STOT SE 1 Oral - STOT SE 2 Oral

target_organs

Central nervous system,Blood, Respiratory system

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk_germany

WGK 2

flash_point_f

260.6 °F - closed cup

flash_point_c

127 °C - closed cup

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Resorcinol.
IARC monographs on the evaluation of carcinogenic risks to humans, 71 Pt 3, 1119-1131 (1999-09-07)
Frank Welsch
International journal of toxicology, 27(1), 59-63 (2008-02-23)
Medical case reports published in the 20th century over the course of several decades show that resorcinol caused reversible adverse effects on the human thyroid gland (TG) manifested as hypothyroidism. Affected patients had ulcerating leg varicosities and underwent prolonged treatment
50% resorcinol peel.
P G Karam
International journal of dermatology, 32(8), 569-574 (1993-08-01)
Ahmed M Elkhatat et al.
Advanced materials (Deerfield Beach, Fla.), 23(26), 2887-2903 (2011-05-25)
An overview on the preparation and properties of resorcinol-formaldehyde (RF) organic and carbon gels reveals the fascinating and remarkably flexible properties of RF carbon and organic gels and how these properties are related to the synthesis and processing conditions. The
Barry S Lynch et al.
Regulatory toxicology and pharmacology : RTP, 36(2), 198-210 (2002-12-04)
Resorcinol administered at high doses to rodents can disrupt thyroid hormone synthesis and can produce goitrogenic effects. These effects were not seen in a 2-year bioassay at doses of up to 520 mg/kg/day. There are species-specific differences in synthesis, binding
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service